¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress : 2020-10-31

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress : 2020-10-31
±³À°ÀÏÀÚ : 2020-10-31
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress      
ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ÇмúÀ§¿øȸ
¿¬¶ôó : 02-564-4367  
À̸ÞÀÏ : aoce-sicem2020@intercom.co.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ÇÙÀÇÇаúÀÇ»çÇÐ, ºÐÀÚ»ý¹°ÇÐ,      
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 27 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 150,000¿ø      
ºñ°í 1. ÀÇ»ç, ±³¼ö - KES ȸ¿ø: 10¸¸¿ø / KES ¹Ìȸ¿ø: 15¸¸¿ø 2. Àü°øÀÇ, ÀüÀÓÀÇ, °£È£»ç, ¿¬±¸ÀÚ, ±âŸ - KES ȸ¿ø: 5¸¸¿ø / KES ¹Ìȸ¿ø: 10¸¸¿ø * º» Çà»ç´Â LIVE°­ÀÇ¿Í ³ìÈ­µÈ VOD°­ÀÇ·Î ÁøÇàµÇ¸ç, VOD °­ÀǵéÀº ¾Æ·¡ ½Ã°£¿¡ °ü°è¾øÀÌ ´çÀÏ ÀÚÁ¤±îÁö ÆíÇѽ𣿡 º¼ ¼ö ÀÖµµ·Ï ¿î¿µÇÒ ¿¹Á¤ÀÔ´Ï´Ù.      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:00~09:30 Primary Aldosteronism and Cardiovascular Health  Mitsuhide Naruse(To Be Discussed) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:30~10:00 Pheochromocytoma and Bone Health  À̽ÂÈÆ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ10:00~10:30 Cushing  Martin Reincke(To Be Discussed) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:00~09:30 In Situ Metabolomics (Mass spectrometry imaging) in Adrenal Tumor  Masanori Murakami(Ludwig-Maximilians-Universität München) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:30~10:00 Adrenocortical Carcinoma  Yuto Yamazaki(Tohoku University Graduate School of Medicine) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ10:00~10:30 Diagnosis and Management of Adrenal Insufficiency  È«¾Æ¶÷(È­¼øÀü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:00~09:30 Diagnosis and Treatment of Growth Hormone Deficiency  ±èÁ¤Èñ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:30~10:00 Pituitary Diseases in Pregnancy  ±èº´ÁØ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ10:00~10:30 Management of Adrenal Incidentaloma  Á¶È£Âù(°è¸íÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:00~09:30 Regulation of Inter-organ Network in Mitochondrial Unfolded Protein Response -Role of Mitokine GDF15 in Mammalian Metabolism  ¼Û¹ÎÈ£(Ãæ³²´ëÇб³) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:30~10:00 Primary Cilia in Developing Hypothalamic Neurons and Adulthood Body Weight  ±è¹Î¼±(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ10:00~10:30 The Role of the Endoplasmic Reticulum Stress on the Development of Leptin Resistance and Obesity  ÀÌÀç¹Î(DGIST) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:00~09:30 To be Discussed  Wiebke Arlt(University of Birmingham) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ09:30~10:00 Action of Neurosteroid Pregnenolone in the Brain  Bon-chu Chung(Academia Sinica) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ10:00~10:30 Novel Implications of Progesterone Receptor Signaling in Breast Cancer  Viroj Boonyaratanakornkit(Chulalongkorn University) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:00~11:30 Laboratory Testing for Diagnosis and Monitoring of Osteoporosis: ÀÌÂ÷¼º °ñ´Ù°øÁõÀÇ °¨º°À» À§ÇÑ °Ë»ç ¹× ¸ð´ÏƼ¸µ ½Ã ÇÊ¿äÇÑ °Ë»ç  ±è¼¼È­(°¡Å縯°üµ¿ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:30~12:00 When and How to Discontinue Denosumab Therapy for Osteoporosis?: µ¥³ë¼ö¸¿ÀÇ ÈÞ¾à, µ¥³ë¼ö¸¿ Áß´Ü ÈÄ °ñÀý À§Çèµµ ¹× ÀÌÈÄ Ä¡·á °èȹ  ±èÇÏ¿µ(°­¸ª¾Æ»êº´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ12:00~12:30 What is the Role of Romosozumab in the Management of Osteoporosis?: °ñ´Ù°øÁõ Ä¡·á¿¡ ÀÖ¾î »õ·Î¿î Ä¡·áÁ¦ÀÎ ·Î¸ð¼ÒÁÖ¸¿À» ¾î¶»°Ô »ç¿ëÇÒ °ÍÀΰ¡?  ÃÖ¿ëÁØ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:00~11:30 Renal Protective Effect of Sodium-glucose Cotransporter 2 Inhibition and Its Underlying Mechanisms in Diabetic Kidney Disease  °íÀº½Ç(°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:30~12:00 Updates in the Management for Diabetic Retinopathy DRCR.net  ÀÌÁØ¿±(¿ï»ê´ëÇб³ ¾Æ»êº´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ12:00~12:30 New Treatments for Type 2 Diabetes and CV Outcomes: Focus on Stroke  Jesse Dawson(University of Glasgow) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:00~11:30 Role of mRNA Modifications in Islet Regulation of Islet Biology in Type 2 Diabetes  Rohit Kulkarni(Joslin Diabetes Center) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:30~12:00 Human Pluripotent Stem Cell-derived Pancreatic Beta Cells for Studying Diabetes Disease Mechanisms  Adrian TEO(Institute of Molecular and Cell Biology (IMCB) A*STAR) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ12:00~12:30 Pancreatic Cancer-related Diabetes - A Unique Model to Understand Glucose Metabolism  °­½Å¾Ö(¿¬¼¼´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:00~11:30 SGLT1/2 Dual Inhibitor  ÀÌÀºÁ¤(°­ºÏ»ï¼ºº´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ11:30~12:00 GLP1/GIP Coagonist LY3298176  Clare Lee(Lily) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ12:00~12:30 Oral GLP1 Agent - Oral Semalgutide  Salvatore Calanna(Novo Nordisk) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ13:00~13:30 Use of Fenofibrate on Cardiovascular Outcomes in Statin Users with Metabolic Syndrome: Propensity Matched Cohort Study  ±è½Å°ï(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ13:30~14:00 Role of Pemafibrate in Cardiometabolic Risk Reduction  Shizuya Yamashita(Rinku General Medical Center) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ14:00~14:30 Very Low LDL-cholesterol Is Safe?  Á¤Àΰæ(°æÈñÀÇ´ë °­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ13:00~13:30 Recent Advances in the Dietary Management of Obesity and Metabolic Disorders  Pornpoj Pramyothin(Siriraj Hospital Mahidol University) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ13:30~14:00 Prevention and Control of Obesity in China (Tentative title)  Youfa Wang(Ball State University) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ13:00~13:30 Pediatric Adrenal Insufficiency: Latest Insight on Diagnosis and Management  Taninee Sahakitrungruang(Faculty of Medicine) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ13:30~14:00 Genetic and Clinical Features including Possible Candidate Genes Responsible for Monogenic Diabetes  ÀüÁ¾±Ù(ºÎ»ê´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ14:00~14:30 A New Era of Genetic Diagnosis of Short Stature  ±èÀ¯¹Ì(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ15:00~15:30 Neuroimaging Analysis of Hypothalamic Obesity Patients  ÃÖÇüÁø(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ15:30~16:00 Appetitive Drive to Promote Hunting  Wei L. Shen(To Be Discussed) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:00~16:30 Epitranional Control of Energy Homeostasis  Daisuke Kohno(To Be Discussed) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ15:00~15:30 Disruptive New Therapies in Skeletal Dysplasia: Changing the Rules of the Game  Ravi Savarirayan(Murdoch Children¡¯s Research Institute) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ15:30~16:00 Genetic Diversity and Therapeutic Approach of Osteogenesis Imperfecta  Á¶ÅÂÁØ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:00~16:30 Long Term ATD Treatment  Imam Subekti(Faculty of Medicine Universitas Indonesia) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:30~17:00 Fibroblasts and the Associated Growth Factors in Graves¡¯ Orbitopathy  Shyang-Rong Shih(National Taiwan University School of Medicine) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ17:00~17:30 Management of Thyroid Storm  Takashi Akamizu(Kuma Hospital) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:00~16:30 Management of Hyperthyroidism during Pregnancy  Á¤ÀçÈÆ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:30~17:00 The role of vitamins and Minerals in Thyroid Disease  ±èÈñ°æ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ17:00~17:30 Safety of the Use of Radioactive Iodine  ¹Ú°æÁØ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:00~16:30 Enigma of the Adrenal SHH Progenitor: Implications for Regenerative Therapies  Gary Hammer(University of Michigan) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:30~17:00 Using Stem Cells to Interrogate MODY  Rohit Kulkarni(Joslin Diabetes Center) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ17:00~17:30 Endocrine Control of Heart Regeneration: Insights Platypus, Armadillos, Bats and Whales  Guo Huang(University of California San Francisco) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:00~16:30 Medical Ethics in the Era of Artificial Intelligence Based on Medical Big Data  ³ªÇضõ(¿©Àǵµ¼º¸ðº´¿ø Á¤½Å°Ç°­ÀÇÇаú) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:30~17:00 What Doctors Should Know About &quotPatients Generated Health DATA (PGHD)  ±èÇ强(°¡Å縯´ëÇб³ ÀÇ·áÁ¤º¸Çб³½Ç) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ17:00~17:30 Artificial Intelligence and Big Data - Let¡¯s standardize first! ÀΰøÁö´É°ú ºòµ¥ÀÌÅÍ - Ç¥ÁØÈ­°¡ ¸ÕÀú!  °­¹Ì¶ó(»ï¼º¼­¿ïº´¿ø °Ç°­ÁõÁøÀÇÇаú) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:00~16:30 Recent Trends in Scholarly Journal Publishing  Çã¼±(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ16:30~17:00 How to Write Editorials after Reviewing Papers  À̼±¿µ(°Ç±¹´ëÇб³º´¿ø) 
±³À°½Ã°£ 10¿ù 31ÀÏ ¿Â¶óÀΠ17:00~17:30 How to Write a Good Research Paper?  ÀÌÀºÁ¤(°­ºÏ»ï¼ºº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѳ»ºÐºñÇÐȸ (¿Â¶óÀÎ) AOCE-SICEM 2020 Virtual Congress : 2020-10-31""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Á¦2ȸ ½Å°æºñ»óÆÀ ½ÉÆ÷Áö¾ö : 2020-10-31
´ÙÀ½±Û ¼­¿ïƯº°½ÃÀÇ»çȸ µ¿ÀÛ±¸ ¿¬¼ö±³À° : 2020-10-30
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 75 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 38 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 45 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 33 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 21 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 21 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 29 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 23 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 14 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 26 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 30 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 30 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 38 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷